Research Calls I
-
Upgrades:
- Airbnb (ABNB) upgraded to Buy from Hold at Jefferies; tgt raised to $185
- Camden Property (CPT) upgraded to Buy from Hold at Jefferies; tgt raised to $139
- CME Group (CME) upgraded to Outperform from Mkt Perform at Raymond James; tgt $287
- Cracker Barrel (CBRL) upgraded to Buy from Hold at Truist; tgt raised to $55
- DocuSign (DOCU) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $75
- Fastenal (FAST) upgraded to Outperform from Mkt Perform at William Blair
- Grainger (GWW) upgraded to Outperform from Mkt Perform at William Blair
- Hudson Pacific Properties (HPP) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $4
- Independence Realty Trust (IRT) upgraded to Buy from Hold at Jefferies; tgt raised to $24
- KeyCorp (KEY) upgraded to Buy from Neutral at Citigroup; tgt $20
- Knight-Swift (KNX) upgraded to Neutral from Sell at Citigroup; tgt $53
- Samsara (IOT) upgraded to Outperform from Market Perform at BMO Capital Markets; tgt $48
- Samsara (IOT) upgraded to Overweight from Neutral at Piper Sandler; tgt $50
- Shift4 Payments (FOUR) upgraded to Strong Buy from Outperform at Raymond James; tgt $140
-
Downgrades:
- Emerson (EMR) downgraded to Underweight from Equal Weight at Barclays; tgt lowered to $110
- Host Hotels (HST) downgraded to Neutral from Buy at Compass Point; tgt lowered to $18
- Jack Henry (JKHY) downgraded to Neutral from Buy at Northcoast
- Kilroy Realty (KRC) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $35
-
Others:
- Aardvark Therapeutics (AARD) initiated with an Overweight at Cantor Fitzgerald; tgt $50
- Aardvark Therapeutics (AARD) initiated with an Outperform at RBC Capital Mkts; tgt $21
- Aardvark Therapeutics (AARD) initiated with a Buy at BofA Securities; tgt $22
- Aardvark Therapeutics (AARD) initiated with an Overweight at Morgan Stanley; tgt $29
- ArriVent BioPharma (AVBP) initiated with a Buy at Guggenheim; tgt $45
- Knife River Corp. (KNF) initiated with a Overweight at Wells Fargo; tgt $102